Skip to main content
Premium Trial:

Request an Annual Quote

ChondroGene Pens Molecular Dx Alliance With Two Malaysian Hospitals

NEW YORK, June 10 (GenomeWeb News) - ChondroGene has partnered with a pair of hospitals in Malaysia to develop a suite of molecular diagnostics for certain diseases based on its Sentinel Principle technology, the company said today.


As part of the alliance, Lam Wah EE Hospital and IslandHospital, located in Penang, will provide ChondroGene with blood samples from patients with cancer, cardiovascular disease, central nervous system disorders, and arthritis, the company said.


ChondroGene, based in Toronto, will use genetic data extracted from these samples to help it identify blood-based biomarkers for specific diseases in these areas. ChondroGene will also add the data to its database of gene-expression profiles, which the firm said currently contains profiles from controls and "several thousand people possessing a wide range of disease conditions."


The hospitals said they would offer ChondroGene's tests to their patients as the diagnostics become available.

K. Wayne Marshall, president and CEO of ChondroGene, said he "expect[s] to enter into similar relationships with other organizations around the world in the future in order to further expand the genetic diversity of our gene expression database. ..."

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.